ID   MK08_HUMAN              Reviewed;         427 AA.
AC   P45983; B5BTZ5; B7ZLV4; D3DX88; D3DX92; Q15709; Q15712; Q15713;
AC   Q308M2;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   10-MAY-2017, entry version 193.
DE   RecName: Full=Mitogen-activated protein kinase 8;
DE            Short=MAP kinase 8;
DE            Short=MAPK 8;
DE            EC=2.7.11.24;
DE   AltName: Full=JNK-46;
DE   AltName: Full=Stress-activated protein kinase 1c;
DE            Short=SAPK1c;
DE   AltName: Full=Stress-activated protein kinase JNK1;
DE   AltName: Full=c-Jun N-terminal kinase 1;
GN   Name=MAPK8; Synonyms=JNK1, PRKM8, SAPK1, SAPK1C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=8137421; DOI=10.1016/0092-8674(94)90380-8;
RA   Derijard B., Hibi M., Wu I.-H., Barrett T., Su B., Deng T., Karin M.,
RA   Davis R.J.;
RT   "JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds
RT   and phosphorylates the c-Jun activation domain.";
RL   Cell 76:1025-1037(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=8654373;
RA   Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K.,
RA   Derijard B., Davis R.J.;
RT   "Selective interaction of JNK protein kinase isoforms with
RT   transcription factors.";
RL   EMBO J. 15:2760-2770(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Lin L., Nong W., Zhou G., Ke R., Shen C., Zhong G., Zheng Z.,
RA   Liang M., Tang Z., Huang B., Li H., Yang S.;
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   MUTAGENESIS.
RX   PubMed=7839144; DOI=10.1126/science.7839144;
RA   Derijard B., Raingeaud J., Barrett T., Wu I.-H., Han J.,
RA   Ulevitch R.J., Davis R.J.;
RT   "Independent human MAP-kinase signal transduction pathways defined by
RT   MEK and MKK isoforms.";
RL   Science 267:682-685(1995).
RN   [9]
RP   PHOSPHORYLATION AT THR-183 AND TYR-185, REGULATION BY MAP2K4 AND
RP   MAP2K7, AND COFACTOR.
RX   PubMed=11062067; DOI=10.1042/bj3520145;
RA   Fleming Y., Armstrong C.G., Morrice N., Paterson A., Goedert M.,
RA   Cohen P.;
RT   "Synergistic activation of stress-activated protein kinase 1/c-Jun N-
RT   terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein
RT   kinase kinase 4 (MKK4) and MKK7.";
RL   Biochem. J. 352:145-154(2000).
RN   [10]
RP   INTERACTION WITH MECOM.
RX   PubMed=10856240; DOI=10.1093/emboj/19.12.2958;
RA   Kurokawa M., Mitani K., Yamagata T., Takahashi T., Izutsu K.,
RA   Ogawa S., Moriguchi T., Nishida E., Yazaki Y., Hirai H.;
RT   "The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents
RT   stress-induced cell death.";
RL   EMBO J. 19:2958-2968(2000).
RN   [11]
RP   FUNCTION IN PHOSPHORYLATION OF HSF1, AND INTERACTION WITH HSF1.
RX   PubMed=10747973; DOI=10.1074/jbc.M000958200;
RA   Dai R., Frejtag W., He B., Zhang Y., Mivechi N.F.;
RT   "c-Jun NH2-terminal kinase targeting and phosphorylation of heat shock
RT   factor-1 suppress its transcriptional activity.";
RL   J. Biol. Chem. 275:18210-18218(2000).
RN   [12]
RP   INTERACTION WITH WWOX AND TP53.
RX   PubMed=12514174; DOI=10.1074/jbc.M208373200;
RA   Chang N.-S., Doherty J., Ensign A.;
RT   "JNK1 physically interacts with WW domain-containing oxidoreductase
RT   (WOX1) and inhibits WOX1-mediated apoptosis.";
RL   J. Biol. Chem. 278:9195-9202(2003).
RN   [13]
RP   INTERACTION WITH SPAG9.
RX   PubMed=15693750; DOI=10.1042/BJ20041577;
RA   Jagadish N., Rana R., Selvi R., Mishra D., Garg M., Yadav S.,
RA   Herr J.C., Okumura K., Hasegawa A., Koyama K., Suri A.;
RT   "Characterization of a novel human sperm-associated antigen 9 (SPAG9)
RT   having structural homology with c-Jun N-terminal kinase-interacting
RT   protein.";
RL   Biochem. J. 389:73-82(2005).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH HSF4.
RX   PubMed=16581800; DOI=10.1128/MCB.26.8.3282-3294.2006;
RA   Hu Y., Mivechi N.F.;
RT   "Association and regulation of heat shock transcription factor 4b with
RT   both extracellular signal-regulated kinase mitogen-activated protein
RT   kinase and dual-specificity tyrosine phosphatase DUSP26.";
RL   Mol. Cell. Biol. 26:3282-3294(2006).
RN   [15]
RP   INTERACTION WITH NFATC4.
RX   PubMed=17875713; DOI=10.1158/0008-5472.CAN-06-4788;
RA   Yao K., Cho Y.-Y., Bergen H.R. III, Madden B.J., Choi B.Y., Ma W.-Y.,
RA   Bode A.M., Dong Z.;
RT   "Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-
RT   AP-1 induced cell transformation.";
RL   Cancer Res. 67:8725-8735(2007).
RN   [16]
RP   PHOSPHORYLATION BY TAOK2.
RX   PubMed=17158878; DOI=10.1074/jbc.M608336200;
RA   Zihni C., Mitsopoulos C., Tavares I.A., Baum B., Ridley A.J.,
RA   Morris J.D.;
RT   "Prostate-derived sterile 20-like kinase 1-alpha induces apoptosis.
RT   JNK-and caspase-dependent nuclear localization is a requirement for
RT   membrane blebbing.";
RL   J. Biol. Chem. 282:6484-6493(2007).
RN   [17]
RP   FUNCTION IN PHOSPHORYLATION OF ELK1.
RX   PubMed=17296730; DOI=10.1128/MCB.02276-06;
RA   Zhang L., Yang S.H., Sharrocks A.D.;
RT   "Rev7/MAD2B links c-Jun N-terminal protein kinase pathway signaling to
RT   activation of the transcription factor Elk-1.";
RL   Mol. Cell. Biol. 27:2861-2869(2007).
RN   [18]
RP   FUNCTION IN PHOSPHORYLATION OF JDP2.
RX   PubMed=18307971; DOI=10.1016/j.ab.2008.01.038;
RA   Murata T., Shinozuka Y., Obata Y., Yokoyama K.K.;
RT   "Phosphorylation of two eukaryotic transcription factors, Jun
RT   dimerization protein 2 and activation transcription factor 2, in
RT   Escherichia coli by Jun N-terminal kinase 1.";
RL   Anal. Biochem. 376:115-121(2008).
RN   [19]
RP   FUNCTION IN PHOSPHORYLATION OF BCL2.
RX   PubMed=18570871; DOI=10.1016/j.molcel.2008.06.001;
RA   Wei Y., Pattingre S., Sinha S., Bassik M., Levine B.;
RT   "JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced
RT   autophagy.";
RL   Mol. Cell 30:678-688(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377 (ISOFORMS 1 AND 3),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301 (ISOFORM 5), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   INTERACTION WITH SERPINB3, AND ENZYME REGULATION.
RX   PubMed=19166818; DOI=10.1016/j.bbrc.2009.01.057;
RA   Zheng B., Matoba Y., Kumagai T., Katagiri C., Hibino T., Sugiyama M.;
RT   "Crystal structure of SCCA1 and insight about the interaction with
RT   JNK1.";
RL   Biochem. Biophys. Res. Commun. 380:143-147(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377 (ISOFORMS 1 AND 3),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301 (ISOFORM 5), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [24]
RP   FUNCTION IN PHOSPHORYLATION OF SIRT1.
RX   PubMed=20027304; DOI=10.1371/journal.pone.0008414;
RA   Nasrin N., Kaushik V.K., Fortier E., Wall D., Pearson K.J.,
RA   de Cabo R., Bordone L.;
RT   "JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.";
RL   PLoS ONE 4:E8414-E8414(2009).
RN   [25]
RP   FUNCTION IN PHOSPHORYLATION OF YAP1.
RX   PubMed=21364637; DOI=10.1038/cddis.2010.7;
RA   Tomlinson V., Gudmundsdottir K., Luong P., Leung K.Y., Knebel A.,
RA   Basu S.;
RT   "JNK phosphorylates Yes-associated protein (YAP) to regulate
RT   apoptosis.";
RL   Cell Death Dis. 1:E29-E29(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   INTERACTION WITH PIN1.
RX   PubMed=21660049; DOI=10.1038/cdd.2011.82;
RA   Park J.E., Lee J.A., Park S.G., Lee D.H., Kim S.J., Kim H.J.,
RA   Uchida C., Uchida T., Park B.C., Cho S.;
RT   "A critical step for JNK activation: isomerization by the prolyl
RT   isomerase Pin1.";
RL   Cell Death Differ. 19:153-161(2012).
RN   [28]
RP   FUNCTION.
RX   PubMed=22441692; DOI=10.1038/embor.2012.37;
RA   Yoshitane H., Honma S., Imamura K., Nakajima H., Nishide S.Y., Ono D.,
RA   Kiyota H., Shinozaki N., Matsuki H., Wada N., Doi H., Hamada T.,
RA   Honma K., Fukada Y.;
RT   "JNK regulates the photic response of the mammalian circadian clock.";
RL   EMBO Rep. 13:455-461(2012).
RN   [29]
RP   FUNCTION IN PHOSPHORYLATION OF BAD.
RX   PubMed=21095239; DOI=10.1016/j.biocel.2010.11.011;
RA   Deng H., Zhang J., Yoon T., Song D., Li D., Lin A.;
RT   "Phosphorylation of Bcl-associated death protein (Bad) by
RT   erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes
RT   to survival of erythropoietin-dependent cells.";
RL   Int. J. Biochem. Cell Biol. 43:409-415(2011).
RN   [30]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21148294; DOI=10.1091/mbc.E10-06-0492;
RA   Wang J., Tang R., Lv M., Wang Q., Zhang X., Guo Y., Chang H., Qiao C.,
RA   Xiao H., Li X., Li Y., Shen B., Zhang J.;
RT   "Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells
RT   is associated with resistance to Fas-mediated apoptosis.";
RL   Mol. Biol. Cell 22:117-127(2011).
RN   [31]
RP   FUNCTION IN PHOSPHORYLATION OF CDT1.
RX   PubMed=21856198; DOI=10.1016/j.molcel.2011.06.021;
RA   Miotto B., Struhl K.;
RT   "JNK1 phosphorylation of Cdt1 inhibits recruitment of HBO1 histone
RT   acetylase and blocks replication licensing in response to stress.";
RL   Mol. Cell 44:62-71(2011).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1-363.
RX   PubMed=15141161; DOI=10.1038/sj.emboj.7600212;
RA   Heo Y.S., Kim S.K., Seo C.I., Kim Y.K., Sung B.J., Lee H.S., Lee J.I.,
RA   Park S.Y., Kim J.H., Hwang K.Y., Hyun Y.L., Jeon Y.H., Ro S.,
RA   Cho J.M., Lee T.G., Yang C.H.;
RT   "Structural basis for the selective inhibition of JNK1 by the
RT   scaffolding protein JIP1 and SP600125.";
RL   EMBO J. 23:2185-2195(2004).
RN   [33]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-171 AND ARG-177.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in various
CC       processes such as cell proliferation, differentiation, migration,
CC       transformation and programmed cell death. Extracellular stimuli
CC       such as proinflammatory cytokines or physical stress stimulate the
CC       stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK)
CC       signaling pathway. In this cascade, two dual specificity kinases
CC       MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1.
CC       In turn, MAPK8/JNK1 phosphorylates a number of transcription
CC       factors, primarily components of AP-1 such as JUN, JDP2 and ATF2
CC       and thus regulates AP-1 transcriptional activity. Phosphorylates
CC       the replication licensing factor CDT1, inhibiting the interaction
CC       between CDT1 and the histone H4 acetylase HBO1 to replication
CC       origins. Loss of this interaction abrogates the acetylation
CC       required for replication initiation. Promotes stressed cell
CC       apoptosis by phosphorylating key regulatory factors including
CC       p53/TP53 and Yes-associates protein YAP1. In T-cells, MAPK8 and
CC       MAPK9 are required for polarized differentiation of T-helper cells
CC       into Th1 cells. Contributes to the survival of erythroid cells by
CC       phosphorylating the antagonist of cell death BAD upon EPO
CC       stimulation. Mediates starvation-induced BCL2 phosphorylation,
CC       BCL2 dissociation from BECN1, and thus activation of autophagy.
CC       Phosphorylates STMN2 and hence regulates microtubule dynamics,
CC       controlling neurite elongation in cortical neurons. In the
CC       developing brain, through its cytoplasmic activity on STMN2,
CC       negatively regulates the rate of exit from multipolar stage and of
CC       radial migration from the ventricular zone. Phosphorylates several
CC       other substrates including heat shock factor protein 4 (HSF4), the
CC       deacetylase SIRT1, ELK1, or the E3 ligase ITCH. Phosphorylates the
CC       CLOCK-ARNTL/BMAL1 heterodimer and plays a role in the regulation
CC       of the circadian clock (PubMed:22441692). Phosphorylates the heat
CC       shock transcription factor HSF1, suppressing HSF1-induced
CC       transcriptional activity (PubMed:10747973).
CC       {ECO:0000269|PubMed:10747973, ECO:0000269|PubMed:22441692}.
CC   -!- FUNCTION: JNK1 isoforms display different binding patterns: beta-1
CC       preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-
CC       2 have a similar low level of binding to both c-Jun or ATF2.
CC       However, there is no correlation between binding and
CC       phosphorylation, which is achieved at about the same efficiency by
CC       all isoforms.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:11062067};
CC   -!- ENZYME REGULATION: Activated by threonine and tyrosine
CC       phosphorylation by either of two dual specificity kinases, MAP2K4
CC       and MAP2K7. MAP2K4 shows a strong preference for Tyr-185 while
CC       MAP2K7 phosphorylates Tyr-183 preferentially. Inhibited by dual
CC       specificity phosphatases, such as DUSP1. Inhibited by SERPINB3.
CC       {ECO:0000269|PubMed:19166818}.
CC   -!- SUBUNIT: Binds to at least four scaffolding proteins,
CC       MAPK8IP1/JIP-1, MAPK8IP2/JIP-2, MAPK8IP3/JIP-3/JSAP1 and
CC       SPAG9/MAPK8IP4/JIP-4. These proteins also bind other components of
CC       the JNK signaling pathway. Interacts with TP53 and WWOX. Interacts
CC       with JAMP. Forms a complex with MAPK8IP1 and ARHGEF28 (By
CC       similarity). Interacts with HSF1 (via D domain and preferentially
CC       with hyperphosphorylated form); this interaction occurs under both
CC       normal growth conditions and immediately upon heat shock
CC       (PubMed:10747973). Interacts (phosphorylated form) with NFE2; the
CC       interaction phosphorylates NFE2 in undifferentiated cells (By
CC       similarity). Interacts with NFATC4. Interacts with MECOM;
CC       regulates JNK signaling. Interacts with PIN1; this interaction
CC       mediates MAPK8 conformational changes leading to the binding of
CC       MAPK8 to its substrates. {ECO:0000250,
CC       ECO:0000269|PubMed:10747973, ECO:0000269|PubMed:10856240,
CC       ECO:0000269|PubMed:12514174, ECO:0000269|PubMed:15693750,
CC       ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:17875713,
CC       ECO:0000269|PubMed:19166818, ECO:0000269|PubMed:21660049}.
CC   -!- INTERACTION:
CC       Q92934:BAD; NbExp=2; IntAct=EBI-286483, EBI-700771;
CC       P22681:CBL; NbExp=2; IntAct=EBI-286483, EBI-518228;
CC       P60953:CDC42; NbExp=2; IntAct=EBI-286483, EBI-81752;
CC       P46108:CRK; NbExp=2; IntAct=EBI-286483, EBI-886;
CC       P05412:JUN; NbExp=4; IntAct=EBI-286483, EBI-852823;
CC       O14733:MAP2K7; NbExp=4; IntAct=EBI-286483, EBI-492605;
CC       O14733-2:MAP2K7; NbExp=3; IntAct=EBI-286483, EBI-492627;
CC       Q9UQF2:MAPK8IP1; NbExp=7; IntAct=EBI-286483, EBI-78404;
CC       Q9WVI9-1:Mapk8ip1 (xeno); NbExp=2; IntAct=EBI-286483, EBI-288461;
CC       P27986:PIK3R1; NbExp=6; IntAct=EBI-286483, EBI-79464;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21148294}.
CC       Nucleus {ECO:0000269|PubMed:21148294}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=2; Synonyms=JNK1-alpha-2;
CC         IsoId=P45983-1; Sequence=Displayed;
CC       Name=1; Synonyms=JNK1-alpha-1;
CC         IsoId=P45983-2; Sequence=VSP_004833;
CC         Note=Contains a phosphoserine at position 377.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195};
CC       Name=3; Synonyms=JNK1-beta-1;
CC         IsoId=P45983-3; Sequence=VSP_004831, VSP_004832, VSP_004833;
CC         Note=Contains a phosphoserine at position 377.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195};
CC       Name=4; Synonyms=JNK1-beta-2;
CC         IsoId=P45983-4; Sequence=VSP_004831, VSP_004832;
CC       Name=5;
CC         IsoId=P45983-5; Sequence=VSP_054554, VSP_004833;
CC         Note=Contains a phosphoserine at position 301.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195};
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-183 and Tyr-185 by MAP2K7 and
CC       MAP2K4, which activates the enzyme. Phosphorylated by TAOK2.
CC       {ECO:0000269|PubMed:11062067, ECO:0000269|PubMed:17158878}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JNK1ID196.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=C-Jun N-terminal kinases entry;
CC       URL="https://en.wikipedia.org/wiki/C-Jun_N-terminal_kinases";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L26318; AAA36131.1; -; mRNA.
DR   EMBL; U34822; AAC50607.1; -; mRNA.
DR   EMBL; U35004; AAC50610.1; -; mRNA.
DR   EMBL; U35005; AAC50611.1; -; mRNA.
DR   EMBL; DQ234352; ABB29981.1; -; mRNA.
DR   EMBL; AC016397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC074325; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB451231; BAG70045.1; -; mRNA.
DR   EMBL; CH471187; EAW93132.1; -; Genomic_DNA.
DR   EMBL; CH471187; EAW93129.1; -; Genomic_DNA.
DR   EMBL; CH471187; EAW93130.1; -; Genomic_DNA.
DR   EMBL; CH471187; EAW93133.1; -; Genomic_DNA.
DR   EMBL; CH471187; EAW93134.1; -; Genomic_DNA.
DR   EMBL; CH471187; EAW93136.1; -; Genomic_DNA.
DR   EMBL; BC144063; AAI44064.1; -; mRNA.
DR   CCDS; CCDS60527.1; -. [P45983-5]
DR   CCDS; CCDS7223.1; -. [P45983-4]
DR   CCDS; CCDS7224.1; -. [P45983-1]
DR   CCDS; CCDS7225.1; -. [P45983-2]
DR   CCDS; CCDS7226.1; -. [P45983-3]
DR   PIR; S71097; S71097.
DR   PIR; S71099; S71099.
DR   RefSeq; NP_001265476.1; NM_001278547.1. [P45983-4]
DR   RefSeq; NP_001265477.1; NM_001278548.1. [P45983-5]
DR   RefSeq; NP_001310231.1; NM_001323302.1. [P45983-2]
DR   RefSeq; NP_001310250.1; NM_001323321.1. [P45983-3]
DR   RefSeq; NP_001310251.1; NM_001323322.1. [P45983-4]
DR   RefSeq; NP_001310252.1; NM_001323323.1. [P45983-4]
DR   RefSeq; NP_001310253.1; NM_001323324.1. [P45983-2]
DR   RefSeq; NP_001310254.1; NM_001323325.1. [P45983-3]
DR   RefSeq; NP_001310255.1; NM_001323326.1. [P45983-2]
DR   RefSeq; NP_001310256.1; NM_001323327.1. [P45983-2]
DR   RefSeq; NP_001310257.1; NM_001323328.1. [P45983-1]
DR   RefSeq; NP_001310258.1; NM_001323329.1. [P45983-1]
DR   RefSeq; NP_001310259.1; NM_001323330.1. [P45983-4]
DR   RefSeq; NP_001310260.1; NM_001323331.1. [P45983-1]
DR   RefSeq; NP_620634.1; NM_139046.3. [P45983-3]
DR   RefSeq; NP_620637.1; NM_139049.3. [P45983-1]
DR   UniGene; Hs.138211; -.
DR   UniGene; Hs.522924; -.
DR   PDB; 1UKH; X-ray; 2.35 A; A=1-363.
DR   PDB; 1UKI; X-ray; 2.70 A; A=1-363.
DR   PDB; 2G01; X-ray; 3.50 A; A/B=1-364.
DR   PDB; 2GMX; X-ray; 3.50 A; A/B=1-364.
DR   PDB; 2H96; X-ray; 3.00 A; A/B=1-364.
DR   PDB; 2NO3; X-ray; 3.20 A; A/B=1-364.
DR   PDB; 2XRW; X-ray; 1.33 A; A=2-364.
DR   PDB; 2XS0; X-ray; 2.60 A; A=1-379.
DR   PDB; 3ELJ; X-ray; 1.80 A; A=1-364.
DR   PDB; 3O17; X-ray; 3.00 A; A/B=1-364.
DR   PDB; 3O2M; X-ray; 2.70 A; A/B=1-364.
DR   PDB; 3PZE; X-ray; 2.00 A; A=7-364.
DR   PDB; 3V3V; X-ray; 2.70 A; A=1-366.
DR   PDB; 3VUD; X-ray; 3.50 A; A=1-364.
DR   PDB; 3VUG; X-ray; 3.24 A; A=1-364.
DR   PDB; 3VUH; X-ray; 2.70 A; A=1-364.
DR   PDB; 3VUI; X-ray; 2.80 A; A=1-364.
DR   PDB; 3VUK; X-ray; 2.95 A; A=1-364.
DR   PDB; 3VUL; X-ray; 2.81 A; A=1-364.
DR   PDB; 3VUM; X-ray; 2.69 A; A=1-364.
DR   PDB; 4AWI; X-ray; 1.91 A; A=1-364.
DR   PDB; 4E73; X-ray; 2.27 A; A=1-363.
DR   PDB; 4G1W; X-ray; 2.45 A; A=1-363.
DR   PDB; 4HYS; X-ray; 2.42 A; A=1-363.
DR   PDB; 4HYU; X-ray; 2.15 A; A=1-363.
DR   PDB; 4IZY; X-ray; 2.30 A; A=1-363.
DR   PDB; 4L7F; X-ray; 1.95 A; A=7-362.
DR   PDB; 4QTD; X-ray; 1.50 A; A=1-363.
DR   PDB; 4UX9; X-ray; 2.34 A; A/B/C/D=1-364.
DR   PDB; 4YR8; X-ray; 2.40 A; A/C/E/F=1-363.
DR   PDBsum; 1UKH; -.
DR   PDBsum; 1UKI; -.
DR   PDBsum; 2G01; -.
DR   PDBsum; 2GMX; -.
DR   PDBsum; 2H96; -.
DR   PDBsum; 2NO3; -.
DR   PDBsum; 2XRW; -.
DR   PDBsum; 2XS0; -.
DR   PDBsum; 3ELJ; -.
DR   PDBsum; 3O17; -.
DR   PDBsum; 3O2M; -.
DR   PDBsum; 3PZE; -.
DR   PDBsum; 3V3V; -.
DR   PDBsum; 3VUD; -.
DR   PDBsum; 3VUG; -.
DR   PDBsum; 3VUH; -.
DR   PDBsum; 3VUI; -.
DR   PDBsum; 3VUK; -.
DR   PDBsum; 3VUL; -.
DR   PDBsum; 3VUM; -.
DR   PDBsum; 4AWI; -.
DR   PDBsum; 4E73; -.
DR   PDBsum; 4G1W; -.
DR   PDBsum; 4HYS; -.
DR   PDBsum; 4HYU; -.
DR   PDBsum; 4IZY; -.
DR   PDBsum; 4L7F; -.
DR   PDBsum; 4QTD; -.
DR   PDBsum; 4UX9; -.
DR   PDBsum; 4YR8; -.
DR   ProteinModelPortal; P45983; -.
DR   SMR; P45983; -.
DR   BioGrid; 111585; 181.
DR   DIP; DIP-249N; -.
DR   IntAct; P45983; 85.
DR   MINT; MINT-1211982; -.
DR   STRING; 9606.ENSP00000353483; -.
DR   BindingDB; P45983; -.
DR   ChEMBL; CHEMBL2276; -.
DR   DrugBank; DB07268; 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE.
DR   GuidetoPHARMACOLOGY; 1496; -.
DR   iPTMnet; P45983; -.
DR   PhosphoSitePlus; P45983; -.
DR   BioMuta; MAPK8; -.
DR   DMDM; 2507195; -.
DR   EPD; P45983; -.
DR   MaxQB; P45983; -.
DR   PaxDb; P45983; -.
DR   PeptideAtlas; P45983; -.
DR   PRIDE; P45983; -.
DR   DNASU; 5599; -.
DR   Ensembl; ENST00000360332; ENSP00000353483; ENSG00000107643. [P45983-5]
DR   Ensembl; ENST00000374176; ENSP00000363291; ENSG00000107643. [P45983-4]
DR   Ensembl; ENST00000374179; ENSP00000363294; ENSG00000107643. [P45983-3]
DR   Ensembl; ENST00000374182; ENSP00000363297; ENSG00000107643. [P45983-2]
DR   Ensembl; ENST00000374189; ENSP00000363304; ENSG00000107643. [P45983-1]
DR   Ensembl; ENST00000395611; ENSP00000378974; ENSG00000107643. [P45983-4]
DR   GeneID; 5599; -.
DR   KEGG; hsa:5599; -.
DR   UCSC; uc001jgm.5; human. [P45983-1]
DR   CTD; 5599; -.
DR   DisGeNET; 5599; -.
DR   GeneCards; MAPK8; -.
DR   HGNC; HGNC:6881; MAPK8.
DR   HPA; CAB004463; -.
DR   HPA; CAB069396; -.
DR   MIM; 601158; gene.
DR   neXtProt; NX_P45983; -.
DR   OpenTargets; ENSG00000107643; -.
DR   PharmGKB; PA283; -.
DR   eggNOG; KOG0665; Eukaryota.
DR   eggNOG; ENOG410XSHI; LUCA.
DR   GeneTree; ENSGT00550000074271; -.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P45983; -.
DR   KO; K04440; -.
DR   OMA; VISGSQH; -.
DR   PhylomeDB; P45983; -.
DR   TreeFam; TF105100; -.
DR   BRENDA; 2.7.11.24; 2681.
DR   Reactome; R-HSA-111446; Activation of BIM and translocation to mitochondria.
DR   Reactome; R-HSA-139910; Activation of BMF and translocation to mitochondria.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-HSA-376172; DSCAM interactions.
DR   Reactome; R-HSA-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-HSA-450341; Activation of the AP-1 family of transcription factors.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   SignaLink; P45983; -.
DR   SIGNOR; P45983; -.
DR   ChiTaRS; MAPK8; human.
DR   EvolutionaryTrace; P45983; -.
DR   GeneWiki; MAPK8; -.
DR   GenomeRNAi; 5599; -.
DR   PRO; PR:P45983; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107643; -.
DR   CleanEx; HS_MAPK8; -.
DR   ExpressionAtlas; P45983; baseline and differential.
DR   Genevisible; P45983; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0035033; F:histone deacetylase regulator activity; IMP:BHF-UCL.
DR   GO; GO:0004705; F:JUN kinase activity; IDA:UniProtKB.
DR   GO; GO:0016301; F:kinase activity; TAS:Reactome.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IDA:CAFA.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IMP:CAFA.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:MGI.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IMP:CAFA.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007254; P:JNK cascade; IDA:UniProtKB.
DR   GO; GO:0007258; P:JUN phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0031281; P:positive regulation of cyclase activity; IMP:CACAO.
DR   GO; GO:0090045; P:positive regulation of deacetylase activity; IMP:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; IMP:CACAO.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:CAFA.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:1902595; P:regulation of DNA replication origin binding; IMP:CAFA.
DR   GO; GO:0016241; P:regulation of macroautophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:BHF-UCL.
DR   GO; GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome.
DR   GO; GO:0006950; P:response to stress; TAS:ProtInc.
DR   GO; GO:0009411; P:response to UV; IDA:MGI.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; IDA:CAFA.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR008351; MAPK_JNK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01772; JNKMAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Biological rhythms;
KW   Complete proteome; Cytoplasm; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; S-nitrosylation;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    427       Mitogen-activated protein kinase 8.
FT                                /FTId=PRO_0000186262.
FT   DOMAIN       26    321       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      32     40       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       183    185       TXY.
FT   ACT_SITE    151    151       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      55     55       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     116    116       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P49185}.
FT   MOD_RES     183    183       Phosphothreonine; by MAP2K7.
FT                                {ECO:0000269|PubMed:11062067}.
FT   MOD_RES     185    185       Phosphotyrosine; by MAP2K4.
FT                                {ECO:0000269|PubMed:11062067}.
FT   MOD_RES     377    377       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91Y86}.
FT   VAR_SEQ     206    281       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_054554.
FT   VAR_SEQ     208    208       L -> I (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_004831.
FT   VAR_SEQ     219    230       VCHKILFPGRDY -> IKGGVLFPGTDH (in isoform
FT                                3 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_004832.
FT   VAR_SEQ     380    427       GAAVINGSQHPSSSSSVNDVSSMSTDPTLASDTDSSLEAAA
FT                                GPLGCCR -> AQVQQ (in isoform 1, isoform 3
FT                                and isoform 5).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:19054851,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_004833.
FT   VARIANT     171    171       G -> S (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042258.
FT   VARIANT     177    177       G -> R (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042259.
FT   VARIANT     365    365       E -> K (in dbSNP:rs45483593).
FT                                /FTId=VAR_050592.
FT   MUTAGEN     183    183       T->A: Phosphorylation blocked.
FT                                {ECO:0000269|PubMed:7839144}.
FT   MUTAGEN     185    185       Y->F: Phosphorylation blocked.
FT                                {ECO:0000269|PubMed:7839144}.
FT   HELIX         4      9       {ECO:0000244|PDB:2XRW}.
FT   STRAND       10     15       {ECO:0000244|PDB:2XRW}.
FT   STRAND       18     23       {ECO:0000244|PDB:2XRW}.
FT   STRAND       26     34       {ECO:0000244|PDB:2XRW}.
FT   STRAND       36     45       {ECO:0000244|PDB:2XRW}.
FT   TURN         46     49       {ECO:0000244|PDB:2XRW}.
FT   STRAND       50     58       {ECO:0000244|PDB:2XRW}.
FT   HELIX        60     62       {ECO:0000244|PDB:4QTD}.
FT   HELIX        64     79       {ECO:0000244|PDB:2XRW}.
FT   STRAND       83     85       {ECO:0000244|PDB:2GMX}.
FT   STRAND       88     92       {ECO:0000244|PDB:2XRW}.
FT   STRAND       94     97       {ECO:0000244|PDB:3VUM}.
FT   TURN         98    100       {ECO:0000244|PDB:2XRW}.
FT   STRAND      103    109       {ECO:0000244|PDB:2XRW}.
FT   STRAND      112    114       {ECO:0000244|PDB:2XRW}.
FT   HELIX       115    120       {ECO:0000244|PDB:2XRW}.
FT   HELIX       125    144       {ECO:0000244|PDB:2XRW}.
FT   HELIX       154    156       {ECO:0000244|PDB:2XRW}.
FT   STRAND      157    159       {ECO:0000244|PDB:2XRW}.
FT   TURN        161    163       {ECO:0000244|PDB:2H96}.
FT   STRAND      165    167       {ECO:0000244|PDB:2XRW}.
FT   STRAND      174    177       {ECO:0000244|PDB:3O2M}.
FT   STRAND      178    180       {ECO:0000244|PDB:2NO3}.
FT   STRAND      182    184       {ECO:0000244|PDB:3ELJ}.
FT   STRAND      185    187       {ECO:0000244|PDB:2G01}.
FT   HELIX       189    191       {ECO:0000244|PDB:3PZE}.
FT   HELIX       194    197       {ECO:0000244|PDB:2XRW}.
FT   HELIX       206    220       {ECO:0000244|PDB:2XRW}.
FT   HELIX       230    241       {ECO:0000244|PDB:2XRW}.
FT   HELIX       246    249       {ECO:0000244|PDB:2XRW}.
FT   HELIX       254    261       {ECO:0000244|PDB:2XRW}.
FT   HELIX       271    274       {ECO:0000244|PDB:2XRW}.
FT   HELIX       277    279       {ECO:0000244|PDB:2XRW}.
FT   HELIX       285    301       {ECO:0000244|PDB:2XRW}.
FT   HELIX       306    308       {ECO:0000244|PDB:2XRW}.
FT   HELIX       312    317       {ECO:0000244|PDB:2XRW}.
FT   HELIX       319    322       {ECO:0000244|PDB:2XRW}.
FT   HELIX       327    330       {ECO:0000244|PDB:2XRW}.
FT   TURN        339    342       {ECO:0000244|PDB:2XRW}.
FT   HELIX       349    363       {ECO:0000244|PDB:2XRW}.
SQ   SEQUENCE   427 AA;  48296 MW;  94FB6BE0358B9B60 CRC64;
     MSRSKRDNNF YSVEIGDSTF TVLKRYQNLK PIGSGAQGIV CAAYDAILER NVAIKKLSRP
     FQNQTHAKRA YRELVLMKCV NHKNIIGLLN VFTPQKSLEE FQDVYIVMEL MDANLCQVIQ
     MELDHERMSY LLYQMLCGIK HLHSAGIIHR DLKPSNIVVK SDCTLKILDF GLARTAGTSF
     MMTPYVVTRY YRAPEVILGM GYKENVDLWS VGCIMGEMVC HKILFPGRDY IDQWNKVIEQ
     LGTPCPEFMK KLQPTVRTYV ENRPKYAGYS FEKLFPDVLF PADSEHNKLK ASQARDLLSK
     MLVIDASKRI SVDEALQHPY INVWYDPSEA EAPPPKIPDK QLDEREHTIE EWKELIYKEV
     MDLEERTKNG VIRGQPSPLG AAVINGSQHP SSSSSVNDVS SMSTDPTLAS DTDSSLEAAA
     GPLGCCR
//
